ReviewBiology2026
Secretion Systems Used by Bacteria to Counteract Fungal Competitors.
Review in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Although bacterial secretion systems (BSSs) are well known to mediate antifungal effects, current evidence remains fragmented, and a framework linking antifungal strategies in bacterial-fungal warfare is still absent. In this context, we survey Type I to XI secretion systems, integrating experimentally validated activities with mechanism-based predictions of antifungal potential. On this basis, we highlight that the antifungal activity of BSSs operates through two different layers: direct fungicidal attack, via effector-mediated disruption of fungal cellular integrity, and ecological competition, through nutrient competition, physical niche occupation, and coordinated population-level activities. Nevertheless, the mechanistic understanding of bacterial antifungal strategies remains limited by simplified experimental models, incomplete effector repertoires, and poorly characterized regulatory networks and environmental cues. Addressing these gaps will require integrated experimental models, advanced high-throughput platforms, and comprehensive multi-omics-guided analyses to elucidate how bacteria suppress fungi and to support future applications. In addition, BSSs represent versatile and programmable platforms for the development of sustainable antifungal interventions in both agricultural and biomedical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.